WallStreetZenWallStreetZen

NASDAQ: ARAY
Accuray Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ARAY

Based on 1 analyst offering 12 month price targets for Accuray Inc

Min Forecast
$0.35+52.17%
Avg Forecast
$0.35+52.17%
Max Forecast
$0.35+52.17%

Should I buy or sell ARAY stock?

Based on 2 analysts offering ratings for Accuray Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ARAY stock forecasts and price targets.

ARAY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-12
lockedlocked$00.00+00.00%2026-05-07

1 of 1

Forecast return on equity

Is ARAY forecast to generate an efficient return?

Company
-40.9%
Industry
20.27%
Market
149.8%
ARAY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ARAY forecast to generate an efficient return on assets?

Company
-3.84%
Industry
11.76%
ARAY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ARAY earnings per share forecast

What is ARAY's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.31
Avg 2 year Forecast
-$0.14

ARAY revenue forecast

What is ARAY's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$421.3M+4.8%
Avg 2 year Forecast
$431.2M+7.27%
ARAY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ARAY revenue growth forecast

How is ARAY forecast to perform vs Medical Devices companies and vs the US market?

Company
3.57%
Industry
7.26%
Market
15.17%
ARAY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ARAY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ARAY vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
ARAY$0.23$0.35+52.17%Hold
HSCS$5.20$8.00+53.85%Buy
PAVM$3.96$57.00+1,339.39%Buy
NSYS$11.79N/AN/A
LFWD$6.92N/AN/A
View Top Medical Device Stocks

Accuray Stock Forecast FAQ

Is Accuray Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ARAY) stock is to Hold ARAY stock.

Out of 2 analysts, 0 (0%) are recommending ARAY as a Strong Buy, 0 (0%) are recommending ARAY as a Buy, 2 (100%) are recommending ARAY as a Hold, 0 (0%) are recommending ARAY as a Sell, and 0 (0%) are recommending ARAY as a Strong Sell.

If you're new to stock investing, here's how to buy Accuray stock.

What is ARAY's earnings growth forecast for 2027-2028?

(NASDAQ: ARAY) Accuray's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 28.66%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 63.5%.

Accuray's earnings in 2026 is -$49,194,000.On average, 3 Wall Street analysts forecast ARAY's earnings for 2027 to be -$36,548,428, with the lowest ARAY earnings forecast at -$35,115,156, and the highest ARAY earnings forecast at -$37,623,382.

In 2028, ARAY is forecast to generate -$17,055,933 in earnings, with the lowest earnings forecast at -$16,387,073 and the highest earnings forecast at -$17,557,578.

What is ARAY's revenue growth forecast for 2027-2028?

(NASDAQ: ARAY) Accuray's forecast annual revenue growth rate of 3.57% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.17%.

Accuray's revenue in 2026 is $401,947,000.On average, 3 Wall Street analysts forecast ARAY's revenue for 2027 to be $50,315,002,467, with the lowest ARAY revenue forecast at $48,341,865,115, and the highest ARAY revenue forecast at $51,794,855,481.

In 2028, ARAY is forecast to generate $51,496,257,213 in revenue, with the lowest revenue forecast at $49,477,732,925 and the highest revenue forecast at $53,011,942,019.

What is ARAY's forecast return on assets (ROA) for 2027-2028?

(NASDAQ: ARAY) forecast ROA is -3.84%, which is lower than the forecast US Medical Devices industry average of 11.76%.

What is ARAY's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ARAY price target, the average ARAY price target is $0.35, with the highest ARAY stock price forecast at $0.35 and the lowest ARAY stock price forecast at $0.35.

The Wall Street analyst predicted that Accuray's share price could reach $0.35 by May 12, 2027. The average Accuray stock price prediction forecasts a potential upside of 52.17% from the current ARAY share price of $0.23.

What is ARAY's Earnings Per Share (EPS) forecast for 2027-2028?

(NASDAQ: ARAY) Accuray's current Earnings Per Share (EPS) is -$0.40. On average, analysts forecast that ARAY's EPS will be -$0.31 for 2027, with the lowest EPS forecast at -$0.29, and the highest EPS forecast at -$0.32. In 2028, ARAY's EPS is forecast to hit -$0.14 (min: -$0.14, max: -$0.15).

What is ARAY's forecast return on equity (ROE) for 2027-2028?

(NASDAQ: ARAY) forecast ROE is -40.9%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.